Malaria Information and Prophylaxis, by Country [M]
| Country | Areas with Malaria | Drug Resistance2 | Malaria Species3 | Recommended Chemoprophylaxis4 | Key Information Needed and Helpful Links to Assess Need for Prophylaxis for Select Countries |
|---|---|---|---|---|---|
| Macau SAR (China) | None | Not Applicable | Not Applicable | Not Applicable | |
| Macedonia | None | Not Applicable | Not Applicable | Not Applicable | |
| Madagascar | All areas, except rare cases in Antananarivo. | Chloroquine | P. falciparum 85%,
P. vivax 5-10%, P. ovale 5% |
All areas except Antananarivo: Atovaquone-proguanil, doxycycline, mefloquine, or tafenoquine6.
Antananarivo: Mosquito avoidance only. |
|
| Madeira Islands (Portugal) | None | Not Applicable | Not Applicable | Not Applicable | |
| Malawi | All | Chloroquine | P. falciparum 90%,
P. malariae, P. ovale, and P. vivax 10% combined |
Atovaquone-proguanil, doxycycline, mefloquine, or tafenoquine6 | |
| Malaysia | Present in rural areas. None in Georgetown, Kuala Lampur, and Penang State (includes Penang Island). | Chloroquine | P. falciparum, P. vivax, P. malariae, P. knowlesi, and P. ovale. |
Rural areas: Atovaquone-proguanil, doxycycline, mefloquine, or tafenoquine6 | 1) City(ies) of travel 2) Province(s) of travel Map of states of Malaysia to determine if a city is within a certain stateExternal |
| Maldives | None | Not Applicable | Not Applicable | Not Applicable | |
| Mali | All | Chloroquine | P. falciparum >85%,
P. ovale 5-10%, P. vivax rare |
Atovaquone-proguanil, doxycycline, mefloquine, or tafenoquine6 | |
| Malta | None | Not Applicable | Not Applicable | Not Applicable | |
| Marshall Islands | None | Not Applicable | Not Applicable | Not Applicable | |
| Martinique (France) | None | Not Applicable | Not Applicable | Not Applicable | |
| Mauritania | All areas except Dakhlet-Nouadhibou and Tiris-Zemour in the north | Chloroquine | P. falciparum >85%,
P. ovale 5-10%, P. vivax rare |
Atovaquone-proguanil, doxycycline, mefloquine, or tafenoquine6 | 1) City(ies) of travel 2) Province(s) of travel Map of regions in Mauritania to determine if a city is within a certain regionExternal |
| Mauritius | None | Not Applicable | Not Applicable | Not Applicable | |
| Mayotte (France) | Rare cases | Chloroquine | P. falciparum 93%, P. vivax 5%, P. malariae and P. ovale 2% |
Mosquito avoidance only | |
| Mexico | Present in Chiapas and southern part of Chihuahua. Rare cases in Campeche, Durango, Jalisco, Nayarit, Quintana Roo, San Luis Potosi, Sinaloa, Sonora, and Tabasco. No malaria along the United States-Mexico border. | None | P. vivax 100% | States of Chiapas and southern part of Chihuahua: Atovaquone-proguanil, chloroquine, doxycycline, mefloquine, primaquine,6 or tafenoquine6. States of Campeche, Durango, Jalisco, Nayarit, Quintana Roo, San Luis Potosi, Sinaloa, Sonora, and Tabasco: Mosquito avoidance only.
|
State(s) of travel
Map of states of Mexico to determine if a city is within a certain stateExternal |
| Micronesia, Federated States of; Includes: Yap Islands, Pohnpei, Chuuk, and Kosrae | None | Not Applicable | Not Applicable | Not Applicable | |
| Moldova | None | Not Applicable | Not Applicable | Not Applicable | |
| Monaco | None | Not Applicable | Not Applicable | Not Applicable | |
| Mongolia | None | Not Applicable | Not Applicable | Not Applicable | |
| Montenegro | None | Not Applicable | Not Applicable | Not Applicable | |
| Montserrat (U.K.) | None | Not Applicable | Not Applicable | Not Applicable | |
| Morocco | None | Not Applicable | Not Applicable | Not Applicable | |
| Mozambique | All | Chloroquine | P. falciparum >90%,
P. malariae, P. ovale, and P. vivax rare |
Atovaquone-proguanil, doxycycline, mefloquine, or tafenoquine6 |
1. Factors that affect local malaria transmission patterns can change rapidly and from year to year, such as local weather conditions, mosquito vector density, and prevalence of infection. Information in these tables is updated regularly.
2. Refers to P. falciparum malaria unless otherwise noted.
3. Estimates of malaria species are based on best available data from multiple sources.
4. Several medications are available for chemoprophylaxis. When deciding which drug to use, consider specific itinerary, length of trip, cost of drug, previous adverse reactions to antimalarials, drug allergies, and current medical history. All travelers should seek medical attention in the event of fever during or after return from travel to areas with malaria.
5. This risk estimate is based largely on cases occurring in US military personnel who travel for extended periods of time with unique itineraries that likely do not reflect the risk for the average US traveler.
6. Primaquine and tafenoquine can cause hemolytic anemia in persons with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Patients must be screened for G6PD deficiency prior to starting primaquine.